348 related articles for article (PubMed ID: 11474023)
1. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates.
Ling TK; Tam PC; Liu ZK; Cheng AF
J Clin Microbiol; 2001 Aug; 39(8):2964-6. PubMed ID: 11474023
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures.
Ling TK; Liu ZK; Cheng AF
J Clin Microbiol; 2003 Oct; 41(10):4705-7. PubMed ID: 14532207
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.
Joyanes P; del Carmen Conejo M; Martínez-Martínez L; Perea EJ
J Clin Microbiol; 2001 Sep; 39(9):3247-53. PubMed ID: 11526158
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
6. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
Patzer JA; Dzierzanowska D; Turner PJ
J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
[TBL] [Abstract][Full Text] [Related]
7. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
[TBL] [Abstract][Full Text] [Related]
8. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
Saghir S; Faiz M; Saleem M; Younus A; Aziz H
Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
[TBL] [Abstract][Full Text] [Related]
9. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
10. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.
Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O
APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures.
Chen JR; Lee SY; Yang BH; Lu JJ
J Microbiol Immunol Infect; 2008 Jun; 41(3):259-64. PubMed ID: 18629422
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the VITEK 2 cards for identification and antimicrobial susceptibility testing of non-glucose-fermenting Gram-negative bacilli.
Hsieh WS; Sung LL; Tsai KC; Ho HT
APMIS; 2009 Apr; 117(4):241-7. PubMed ID: 19343822
[TBL] [Abstract][Full Text] [Related]
13. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
14. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
Sader HS; Fritsche TR; Jones RN
J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods.
Funke G; Funke-Kissling P
J Clin Microbiol; 2004 Sep; 42(9):4067-71. PubMed ID: 15364991
[TBL] [Abstract][Full Text] [Related]
17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
18. Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing.
Nakasone I; Kinjo T; Yamane N; Kisanuki K; Shiohira CM
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):191-8. PubMed ID: 17300904
[TBL] [Abstract][Full Text] [Related]
19. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
Ruczkowska J; Dolna I
Przegl Lek; 1992; 49(5):151-3. PubMed ID: 1438917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
